3 Stocks in Takeover Talks – Week of 9/17

Takeover deals can be a signal of positive market sentiment, indicating that the acquiring company is confident in its growth prospects and is willing to invest in expanding its market share. Such deals often lead to an increase in stock prices as they indicate potential value creation and synergies for the acquiring company. Takeover deals may provide an opportunity for investors to capitalize on market inefficiencies and earn profits through arbitrage strategies, such as buying the target company’s stock at a discount to the offer price and profiting from the price convergence upon deal completion.

Here are three takeover targets for the week –

Navios Maritime Holdings Inc. – SYM: NM
Recent Price: $1.93
Takeover Action: Navios Maritime Holdings (NM) announced that its board of directors received an unsolicited non-binding proposal from N Shipmanagement Acquisition to acquire all of the outstanding shares not already owned by NSC and its affiliates for $1.84 in cash per common share.
Description: Navios Maritime Holdings Inc. operates as a seaborne shipping and logistics company in North America, Australia, Europe, Asia, South America, and internationally. It focuses on the transportation and transshipment of dry bulk commodities, including iron ores, coal, and grains. The company operates in two segments, Dry Bulk Vessel Operations and Logistics Business.

===
Stocks of the Month: 7 Stocks Primed for Price Jumps – Free Report from Zacks

This just-released Special Report reveals the 7 most explosive stocks from the list of current Zacks Rank #1 Strong Buys. Recent picks have soared as much as +43%, +45%, even +56% within 30 days, and our newest recommendations could be even more profitable.

Click here to download this report FREE.
===

Eliem Therapeutics, Inc. – SYM: ELYM
Recent Price: $2.68
Takeover Action: Eliem Therapeutics (ELYM) announces plans to conduct a comprehensive exploration of strategic alternatives focused on maximizing shareholder value. It notes that this may result in the sale of the company or some of its assets.
Description: Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial. The company was incorporated in 2018 and is headquartered in Redmond, Washington.

===

WestRock Company – SYM: WRK
Recent Price: $36.51
Takeover Action: Smurfit Kappa Group Plc agreed to acquire WestRock Co. in an $11.2 billion deal that creates an Irish-American packaging industry powerhouse.
Description: WestRock Company, together with its subsidiaries, provides fiber-based paper and packaging solutions in North America, South America, Europe, Asia, and Australia. It operates in four segments, Corrugated Packaging, Consumer Packaging, Global Paper, and Distribution. The Corrugated Packaging segment produces containerboards, corrugated sheets, corrugated packaging, and preprinted linerboards to consumer and industrial products manufacturers, and corrugated box manufacturers. It also provides structural and graphic design, engineering services and custom, and proprietary and standard automated packaging machines, as well as turn-key installation, automation, line integration, and packaging solutions; and pack temporary displays, as well as lithographic laminated packaging products. The Consumer Packaging segment manufactures and sells folding cartons that are used to package food, paper, beverages, dairy products, tobacco, confectionery, health and beauty, other household consumer products; and express mail packages for the overnight courier industry. It also offers inserts and labels, as well as rigid packaging and other printed packaging products, such as transaction cards, brochures, product literature, marketing materials, and grower tags, and plant stakes; and secondary packages and paperboard packaging for over-the-counter and prescription drugs. In addition, this segment manufactures and sells solid fiber and corrugated partitions, and die-cut paperboard components. The Global Paper segment manufactures containerboard, paperboard, and specialty grades primarily to corrugated packaging, folding carton, food service, liquid packaging, tobacco, and commercial print markets. The Distribution segment distributes corrugated packaging materials and other specialty packaging products, including stretch films, void fills, carton sealing tapes, and other specialty tapes; and provides contract packing services. The company was incorporated in 2018 and is based in Atlanta, Georgia.